
Persistent post-meal fatigue, frequent hunger and weight gain around the abdomen are often dismissed as stress or poor lifestyle habits. However, these subtle changes may be early signs of insulin resistance.
Insulin resistance develops gradually and rarely causes obvious symptoms in its early stages. Influenced by lifestyle habits, dietary patterns and genetics, it can quietly affect metabolism long before blood sugar levels become abnormal. Addressing insulin resistance early can help reduce the risk of type 2 diabetes, cardiovascular disease and fatty liver disease while supporting better long-term metabolic health.
In this blog, we explain what insulin resistance is, the early signs to look out for, who may be at greater risk and the steps that can help improve insulin sensitivity and protect your health.

Insulin is a hormone produced by the pancreas that helps regulate blood sugar levels. After a meal, carbohydrates are broken down into glucose, which enters the bloodstream. Insulin allows glucose to move from the blood into the body's cells, where it is used for energy.
Insulin resistance occurs when the body's cells become less responsive to insulin [1]. As a result, glucose is less effectively absorbed by the cells, prompting the pancreas to produce more insulin to maintain normal blood sugar levels. Over time, this increased demand can place strain on the pancreas and contribute to rising blood sugar levels.
Although insulin resistance often develops silently, its effects can extend far beyond blood sugar levels. Over time, persistently elevated insulin and glucose levels can increase the risk of developing Type 2 Diabetes, Non-alcoholic Fatty Liver Disease and Cardiovascular Disease. Early identification and management of insulin resistance can help reduce the likelihood of these complications and support better long-term metabolic health.
Early signs of insulin resistance often develop gradually and can be easy to miss in day-to-day life. They are frequently mistaken for routine fatigue, stress or minor dietary issues. Paying attention to these early changes can help identify underlying metabolic concerns and reduce the risk of more serious complications over time.
Although insulin resistance can affect anyone, it is more commonly seen in people with certain metabolic conditions, body-composition patterns or inherited risk factors.
Ageing, physical inactivity, poor sleep, smoking and certain hormonal or medical conditions can further increase the likelihood of developing insulin resistance. Importantly, appearance or body weight alone cannot confirm or exclude the condition.

It is advisable to seek medical evaluation if early symptoms persist or begin to affect daily functioning. Ongoing fatigue, frequent hunger or difficulty maintaining energy levels despite regular meals may indicate underlying metabolic imbalance. Individuals with a strong family history of Type 2 Diabetes should be particularly mindful, as genetic predisposition can increase the likelihood of developing insulin resistance at an earlier stage.
Medical attention is also important if routine screening tests show borderline or abnormal results, even in the absence of clear symptoms. Difficulty losing weight despite consistent dietary control and physical activity may further suggest reduced insulin sensitivity. Early assessment allows for timely intervention, helping to prevent progression to more serious metabolic conditions and enabling a more targeted approach to management.
An endocrinologist can assess your overall metabolic health, identify factors contributing to insulin resistance and determine whether related conditions such as prediabetes, Type 2 Diabetes, PCOS or fatty liver disease are present. This typically involves a review of symptoms, medical history, lifestyle habits and blood test results.
Based on the findings, a personalised management plan can be developed to improve insulin sensitivity and reduce long-term health risks. This may include dietary guidance, exercise recommendations, weight management strategies, metabolic monitoring and medical treatment where appropriate.
For most individuals, treatment begins with lifestyle modifications, while medication may be recommended for selected patients depending on their overall metabolic health and treatment goals.
Lifestyle changes form the foundation of insulin resistance treatment. A balanced diet rich in whole foods, lean protein, healthy fats and fibre can help support more stable blood sugar levels while reducing excessive insulin demand. Regular physical activity, including both aerobic exercise and resistance training, helps the muscles use glucose more efficiently and improves insulin sensitivity.
Weight management may also play an important role. For individuals who are overweight or obese, even modest weight loss can lead to meaningful improvements in insulin sensitivity and overall metabolic health. Adequate sleep, effective stress management and smoking cessation further support healthy glucose regulation and may reduce the progression of insulin resistance.

GLP-1 receptor agonists mimic the action of glucagon-like peptide-1, a hormone naturally released by the gut after eating. When blood glucose is elevated, these medications help the pancreas release insulin while reducing glucagon, a hormone that prompts the liver to release glucose. They may also slow gastric emptying, reduce appetite and help patients feel satisfied with less food.
For people living with obesity or are overweight, the resulting reduction in calorie intake and body weight, particularly excess visceral and liver fat, can help the muscles and liver respond more effectively to insulin. This improves insulin sensitivity and reduces the amount of insulin needed to regulate blood sugar.
Dual GIP/GLP-1 receptor agonists act on both GIP and GLP-1 pathways. They similarly support glucose-dependent insulin release, reduce glucagon levels and promote weight loss. Tirzepatide, for example, has also demonstrated increased insulin sensitivity in clinical studies.
These medications are generally prescribed for approved indications such as type 2 diabetes or chronic weight management where it has caused metabolic disease such as hypertension/ dyslipidaemia/ Metabolic dysfunction associated with steatotic liver disease, rather than insulin resistance alone. An endocrinologist can assess whether they are appropriate based on the individual’s overall health, treatment goals and potential risks.
Regular follow-up allows treatment to be adjusted as metabolic health changes over time. Blood tests, weight, blood pressure and other metabolic markers may be monitored periodically to assess progress and identify any changes that require further intervention. Ongoing monitoring also provides an opportunity to reinforce healthy lifestyle habits and optimise long-term metabolic health.
Although receiving a diagnosis of insulin resistance may feel concerning, identifying it early is actually an opportunity to take action before it progresses to more serious metabolic conditions. In many individuals, insulin resistance can be significantly improved and, in some cases, return to normal when it is recognised early and managed with appropriate lifestyle changes and medical treatment where needed.
If you are experiencing symptoms of insulin resistance or have concerns about your metabolic health, schedule a consultation with The Metabolic Clinic. Early assessment allows for personalised treatment that can help improve insulin sensitivity, reduce the risk of developing prediabetes or type 2 diabetes, and support better long-term health.
Insulin resistance and prediabetes are closely related but not the same [6]. Insulin resistance refers to the reduced responsiveness of the body’s cells to insulin, which can occur even when blood sugar levels are still within the normal range. Prediabetes, on the other hand, is a clinical condition defined by blood sugar levels that are higher than normal but not yet high enough for a diabetes diagnosis.
In many cases, insulin resistance precedes prediabetes and contributes to its development. As the body becomes less able to maintain normal glucose levels, measurable changes appear in blood tests such as fasting glucose or HbA1c. Recognising this distinction is important, as addressing insulin resistance early can help prevent or delay progression to prediabetes and eventually Type 2 Diabetes.
Insulin resistance tends to progress quietly if it is not addressed. Over time, the body’s ability to maintain normal blood sugar levels becomes increasingly impaired, placing strain on multiple systems. What begins as a subtle metabolic imbalance can gradually lead to more established and difficult-to-manage health conditions.
Addressing insulin resistance early provides an opportunity to prevent or delay these outcomes and maintain better long-term health.

Insulin resistance is not identified through a single test but through a combination of clinical assessment and laboratory findings. Doctors look at patterns in blood sugar, insulin levels and related markers to understand how the body is responding over time.
These tests are interpreted together, alongside symptoms and risk factors, to form a clearer picture of metabolic health.
Management of insulin resistance is most effective when it is tailored to the individual. A specialist approach focuses on identifying underlying drivers and applying targeted strategies that can be sustained over time.
This approach supports gradual, measurable improvement while reducing the risk of progression to more serious metabolic conditions.
Lifestyle changes play a central role in improving insulin sensitivity and slowing the progression of metabolic disease. Small, consistent adjustments in daily habits can lead to meaningful improvements in how the body regulates blood sugar over time.
These changes are most effective when they are sustainable and tailored to individual needs, forming the foundation of long-term metabolic health.
Diet plays a key role in improving insulin sensitivity and maintaining stable blood sugar levels. The focus is not on strict restriction, but on choosing foods that support a steady release of glucose and reduce unnecessary spikes in insulin.
This approach supports long-term metabolic health and is most effective when adapted to individual preferences and lifestyle.

MBBS (Hons), FRACP (Australia)
Dr Dinesh graduated with honours from Monash University, Melbourne in 2009, receiving the Prince Henry's Prize in Surgery. During his endocrinology training in Melbourne, he won the top registrar award at the Endocrine Society of Australia Clinical Weekend in 2016, followed by securing Australia's only Andrology fellowship in 2017. Upon returning to Singapore, he was the sub-speciality lead for adrenal, pituitary, and bone services at Khoo Teck Puat Hospital and established The Metabolic Bone Clinic.
A passionate educator, he served as Associate Programme Director for Endocrinology at NHG, training the next generation of endocrinologists, and received the NHG Teaching Award for Senior Doctors in 2023. An expert endocrinologist with proficiency in both general and sub-speciality endocrinology, he has an interest in longevity through improving cardiovascular risk, metabolism, bone health, and muscle loss prevention, with the ultimate aim of improving the number of healthy years in one's life.

If you’re not achieving your treatment targets, struggling with weight changes, fatigue, or unexplained symptoms—it’s time to take a deeper look.
Get clarity with a tailored plan built around you and improving your metabolic health.
MONDAY - FRIDAY
8:30am – 1:00pm
2:00pm – 5:30pm
SATURDAY
8:30 am – 12:30 pm
Closed on Sun and PH
© 2026 The Metabolic Clinic. All rights reserved.